Priam Villalonga
Palma, PM, Spain
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 16 publications
Editorial expression of concern: Retama monosperma n-hexane extract induces cell cycle arrest and extrinsic pathway-dependent apoptosis in jurkat cells.
Journal: BMC complementary medicine and therapies
Published: November 05, 2022
Glioblastoma Embryonic-like Stem Cells Exhibit Immune-Evasive Phenotype.
Journal: Cancers
Published: March 25, 2022
Toward a Rational Design of Polyamine-Based Zinc-Chelating Agents for Cancer Therapies.
Journal: Journal of medicinal chemistry
Published: January 15, 2020
The tumor suppressor FOXO3a mediates the response to EGFR inhibition in glioblastoma cells.
Journal: Cellular oncology (Dordrecht, Netherlands)
Published: March 25, 2019
Comparison of commercial 5-aminolevulinic acid (Gliolan®) and the pharmacy-compounded solution fluorescence in glioblastoma.
Journal: Acta neurochirurgica
Published: November 21, 2018
INDUCTION OF CELL CYCLE ARREST AND APOPTOSIS BY ORMENIS ERIOLEPIS A MORROCAN ENDEMIC PLANT IN VARIOUS HUMAN CANCER CELL LINES.
Journal: African journal of traditional, complementary, and alternative medicines : AJTCAM
Published: June 03, 2017
N-(2-methyl-indol-1H-5-yl)-1-naphthalenesulfonamide: A novel reversible antimitotic agent inhibiting cancer cell motility.
Journal: Biochemical pharmacology
Published: April 25, 2016
Efficacy of the GemOx-R regimen leads to the identification of Oxaliplatin as a highly effective drug against Mantle Cell Lymphoma.
Journal: British journal of haematology
Published: December 22, 2015
Cell uptake and localization studies of squaramide based fluorescent probes.
Journal: Bioconjugate chemistry
Published: July 19, 2014
Retama monosperma n-hexane extract induces cell cycle arrest and extrinsic pathway-dependent apoptosis in Jurkat cells.
Journal: BMC complementary and alternative medicine
Published: October 02, 2013
Last Updated: 09/26/2026